Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated Cardiotoxicity

Benjamin Buck(The Ohio State University Wexner Medical Center), Daniel Addison(The University of Texas Southwestern Medical Center), Tracy Wiczer(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jennifer A. Woyach(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Orlando P. Simonetti(The Ohio State University), Haseeb Nawaz(Southern Illinois University School of Medicine), John Alan Gambril(The Ohio State University Wexner Medical Center), Patrick Ruz(The Ohio State University Wexner Medical Center), Lai Wei(Tongji University), Subha V. Raman, Kerry A. Rogers(The Ohio State University), Avirup Guha(The Ohio State University), Seema A. Bhat(The Ohio State University), Farrukh T. Awan(The University of Texas Southwestern Medical Center), Janice M. Bonsu(The Ohio State University Wexner Medical Center), Adam S. Kittai(Icahn School of Medicine at Mount Sinai), Grant M. Wallace(The Ohio State University Wexner Medical Center), James W. Mann(The Ohio State University Wexner Medical Center), Aaron Chum(The Ohio State University Wexner Medical Center), Mitkumar Patel(The Ohio State University Wexner Medical Center), Devin Haddad(The Ohio State University Wexner Medical Center), Rebecca Carter(ICLEI - Local Governments for Sustainability USA), Reynaldo Sanchez(The Ohio State University Wexner Medical Center), John C. Byrd(University of Cincinnati), Vedat Yildiz(The Ohio State University), Onaopepo Kola‐Kehinde(The Ohio State University Wexner Medical Center)
JAMA Oncology
February 2, 2023
Cited by 29


Related Papers